Newron Pharmaceuticals SpA - Strategy, SWOT and Corporate Finance Report

Newron Pharmaceuticals SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Newron Pharmaceuticals SpA (Newron Pharmaceuticals) is a research-based biopharmaceutical company which focuses on the discovery, development and commercialization of novel therapeutic drugs for the treatment of central nervous system disorders and pain. The company’s marketed product, Xadago (safinamide), is developed as an adjunctive therapy for any stage of Parkinson's disease. Newron’s other products in pipeline include ralfinamide for neuropathic pain; sarizotan for Rett syndrome; and Evenamide (NW-3509) for the treatment of schizophrenia. The company has development and commercialization collaborations with Zambon and Meiji Seika Pharma Co Ltd. It operates along with its subsidiaries in the UK, Sweden, Switzerland and the US. Newron is headquartered in Bresso, Milan, Italy.

Scope

  • Detailed information on Newron Pharmaceuticals SpA required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Newron Pharmaceuticals SpA in the form of a SWOT analysis
  • An in-depth view of the business model of Newron Pharmaceuticals SpA including a breakdown and examination of key business segments
  • News about Newron Pharmaceuticals SpA, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Newron Pharmaceuticals SpA and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Newron Pharmaceuticals SpA as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Newron Pharmaceuticals SpAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Silence Therapeutics Plc

Santhera Pharmaceuticals Holding AG

Pharming Group NV

Nanobiotix SA

Biotie Therapies Corp

Biofrontera AG

AC Immune SA

Silence Therapeutics Plc

Santhera Pharmaceuticals Holding AG

Pharming Group NV

Nanobiotix SA

Biotie Therapies Corp

Biofrontera AG

AC Immune SA

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Newron Pharmaceuticals SpA - Key Facts

Newron ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Newron Pharmaceuticals SpA - Key Facts

Newron Pharmaceuticals SpA - Key Employees

Newron Pharmaceuticals SpA - Key Employee Biographies

Newron Pharmaceuticals SpA - Major Products and Services

Newron Pharmaceuticals SpA - History

Newron Pharmaceuticals SpA - Company Statement

Newron Pharmaceuticals SpA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Newron Pharmaceuticals SpA - Business Description

R&D Overview

Newron Pharmaceuticals SpA - Corporate Strategy

Newron Pharmaceuticals SpA - SWOT Analysis

SWOT Analysis - Overview

Newron Pharmaceuticals SpA - Strengths

Newron Pharmaceuticals SpA - Weaknesses

Newron Pharmaceuticals SpA - Opportunities

Newron Pharmaceuticals SpA - Threats

Newron Pharmaceuticals SpA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Newron Pharmaceuticals SpA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Newron Pharmaceuticals SpA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Newron Pharmaceuticals SpA, Recent Deals Summary

Section 5 – Company’s Recent Developments

Sep 12, 2019: Newron reports half-year 2019 results

Jun 28, 2019: Newron receives first tranche from financing agreement with European Investment Bank (EIB)

Mar 05, 2019: Newron announces 2018 financial results and provides outlook for 2019

Oct 30, 2018: Investment plan for Europe: EIB backs Italian CNS drug developer Newron Pharmaceuticals with up to EUR 40m

Sep 13, 2018: Newron reports half-year 2018 results

Mar 27, 2018: Newron Pharmaceuticals Announces Shareholders Accepted All Motions at the AGM 2018

Mar 01, 2018: Newron Announces 2017 Financial Results and Provides Outlook for 2018

Feb 13, 2018: Newron Supports Global Rare Disease Day 2018 and Rett Syndrome Studies

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Newron Pharmaceuticals SpA, Key Facts

Newron Pharmaceuticals SpA, Key Employees

Newron Pharmaceuticals SpA, Key Employee Biographies

Newron Pharmaceuticals SpA, Major Products and ...

List of Tables

Newron Pharmaceuticals SpA, Key Facts

Newron Pharmaceuticals SpA, Key Employees

Newron Pharmaceuticals SpA, Key Employee Biographies

Newron Pharmaceuticals SpA, Major Products and Services

Newron Pharmaceuticals SpA, History

Newron Pharmaceuticals SpA, Subsidiaries

Newron Pharmaceuticals SpA, Key Competitors

Newron Pharmaceuticals SpA, Ratios based on current share price

Newron Pharmaceuticals SpA, Annual Ratios

Newron Pharmaceuticals SpA, Annual Ratios (Cont...1)

Newron Pharmaceuticals SpA, Interim Ratios

Newron Pharmaceuticals SpA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Newron Pharmaceuticals SpA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Newron Pharmaceuticals SpA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Newron Pharmaceuticals SpA, Performance Chart (2014 - 2018)

Newron Pharmaceuticals SpA, Ratio Charts

Newron Pharmaceuticals SpA, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Newron Pharmaceuticals SpA, Performance Chart (2014 - 2018)

Newron Pharmaceuticals SpA, Ratio Charts

Newron Pharmaceuticals SpA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Newron Pharmaceuticals SpA, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports